CKD Bio Corp.
KRX:063160.KS
29,400 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | CKD Bio Corp. |
Symbool | 063160.KS |
Munteenheid | KRW |
Prijs | 29,700 |
Beurswaarde | 162,932,922,900 |
Dividendpercentage | 0% |
52-weken bereik | 19,050 - 35,700 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jang-Han Lee |
Website | https://www.ckdbio.com |
An error occurred while fetching data.
Over CKD Bio Corp.
CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)